S&P BSE SENSEX (SENSEX.BO)

Close: 50 297.00 (+447.05), Mar 2, 2021
Weak Positive

Medium risk

Automatic technical analysis. Medium term, Mar 2, 2021

S&P BSE SENSEX is in a rising trend channel in the medium long term. This shows that investors over time have bought the index at higher prices and indicates good development for the market. The index is approacing resistance at 52000 points, which may give a negative reaction. However, a break upwards through 52000 points will be a positive signal. The index is assessed as technically slightly positive for the medium long term.

Recommendation one to six months: Weak Positive (Score: 37)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-1.10%0.00+0.90%
5 days0.003.68%0.00+1.10%
22 days0.0010.78%0.00+8.67%
66 days0.0026.33%0.00+12.97%

More analyses of S&P BSE SENSEX

chart S&P BSE SENSEX (SENSEX) Candlesticks 22 Days
Candlesticks
chart S&P BSE SENSEX (SENSEX) Short term
Short term: Positive
chart S&P BSE SENSEX (SENSEX) Medium term
Medium term: Weak Positive
chart S&P BSE SENSEX (SENSEX) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK